{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:26:29Z","timestamp":1770287189091,"version":"3.49.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,21]]},"DOI":"10.7759\/cureus.76156","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T02:18:48Z","timestamp":1734833928000},"source":"Crossref","is-referenced-by-count":2,"title":["Neurodevelopmental Abnormalities in Down Syndrome: Assessing Structural and Functional Deficits"],"prefix":"10.7759","author":[{"given":"Joelle","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Spey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurjinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134569","article-title":"Neurodevelopmental wiring deficits in the Ts65Dn mouse model of Down syndrome","volume":"714","author":"Jain S","year":"2020","unstructured":"Jain S, Watts CA, Chung WC, Welshhans K. Neurodevelopmental wiring deficits in the Ts65Dn mouse model of Down syndrome. Neurosci Lett. 2020, 714:10.1016\/j.neulet.2019.134569","journal-title":"Neurosci Lett"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70112-5","article-title":"Cognitive deficits and associated neurological complications in individuals with Down's syndrome","volume":"9","author":"Lott IT","year":"2010","unstructured":"Lott IT, Dierssen M. Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol. 2010, 9:623-33. 10.1016\/S1474-4422(10)70112-5","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2019.01.001","article-title":"Down syndrome: neurobiological alterations and therapeutic targets","volume":"98","author":"Vacca RA","year":"2019","unstructured":"Vacca RA, Bawari S, Valenti D, et al.. Down syndrome: neurobiological alterations and therapeutic targets. Neurosci Biobehav Rev. 2019, 98:234-55. 10.1016\/j.neubiorev.2019.01.001","journal-title":"Neurosci Biobehav Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.24230","article-title":"Down syndrome is accompanied by significantly reduced cortical grey-white matter tissue contrast","volume":"39","author":"Bletsch A","year":"2018","unstructured":"Bletsch A, Mann C, Andrews DS, Daly E, Tan GM, Murphy DG, Ecker C. Down syndrome is accompanied by significantly reduced cortical grey-white matter tissue contrast. Hum Brain Mapp. 2018, 39:4043-54. 10.1002\/hbm.24230","journal-title":"Hum Brain Mapp"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01385-w","article-title":"Neurogenesis and neuronal differentiation in the postnatal frontal cortex in Down syndrome","volume":"10","author":"Utagawa EC","year":"2022","unstructured":"Utagawa EC, Moreno DG, Schafernak KT, Arva NC, Malek-Ahmadi MH, Mufson EJ, Perez SE. Neurogenesis and neuronal differentiation in the postnatal frontal cortex in Down syndrome. Acta Neuropathol Commun. 2022, 10:86. 10.1186\/s40478-022-01385-w","journal-title":"Acta Neuropathol Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.4.564","article-title":"MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia","volume":"156","author":"Aylward EH","year":"1999","unstructured":"Aylward EH, Li Q, Honeycutt NA, et al.. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. Am J Psychiatry. 1999, 156:564-8. 10.1176\/ajp.156.4.564","journal-title":"Am J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/101542","article-title":"From abnormal hippocampal synaptic plasticity in Down syndrome mouse models to cognitive disability in Down syndrome","volume":"2012","author":"Cramer N","year":"2012","unstructured":"Cramer N, Galdzicki Z. From abnormal hippocampal synaptic plasticity in Down syndrome mouse models to cognitive disability in Down syndrome. Neural Plast. 2012, 2012:101542. 10.1155\/2012\/101542","journal-title":"Neural Plast"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.10.1659","article-title":"Neuroanatomy of Down's syndrome: a high-resolution MRI study","volume":"158","author":"Pinter JD","year":"2001","unstructured":"Pinter JD, Eliez S, Schmitt JE, Capone GT, Reiss AL. Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am J Psychiatry. 2001, 158:1659-65. 10.1176\/appi.ajp.158.10.1659","journal-title":"Am J Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.06.001","article-title":"Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice","volume":"70","author":"Ash JA","year":"2014","unstructured":"Ash JA, Velazquez R, Kelley CM, Powers BE, Ginsberg SD, Mufson EJ, Strupp BJ. Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice. Neurobiol Dis. 2014, 70:32-42. 10.1016\/j.nbd.2014.06.001","journal-title":"Neurobiol Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0534-10.2010","article-title":"Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome","volume":"30","author":"Bianchi P","year":"2010","unstructured":"Bianchi P, Ciani E, Guidi S, et al.. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. J Neurosci. 2010, 30:8769-79. 10.1523\/JNEUROSCI.0534-10.2010","journal-title":"J Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.10.009","article-title":"Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome","volume":"45","author":"Kleschevnikov AM","year":"2012","unstructured":"Kleschevnikov AM, Belichenko PV, Gall J, et al.. Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis. 2012, 45:683-91. 10.1016\/j.nbd.2011.10.009","journal-title":"Neurobiol Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.09.025","article-title":"Dendritic spine pathology and thrombospondin-1 deficits in Down syndrome","volume":"114","author":"Torres MD","year":"2018","unstructured":"Torres MD, Garcia O, Tang C, Busciglio J. Dendritic spine pathology and thrombospondin-1 deficits in Down syndrome. Free Radic Biol Med. 2018, 114:10-4. 10.1016\/j.freeradbiomed.2017.09.025","journal-title":"Free Radic Biol Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2852-13.2014","article-title":"Prefrontal deficits in a murine model overexpressing the Down syndrome candidate gene Dyrk1a","volume":"34","author":"Thomazeau A","year":"2014","unstructured":"Thomazeau A, Lassalle O, Iafrati J, et al.. Prefrontal deficits in a murine model overexpressing the Down syndrome candidate gene Dyrk1a. J Neurosci. 2014, 34:1138-47. 10.1523\/JNEUROSCI.2852-13.2014","journal-title":"J Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-183X.2006.00224.x","article-title":"Dendritic pathology in mental retardation: from molecular genetics to neurobiology","volume":"5 Suppl 2","author":"Dierssen M","year":"2006","unstructured":"Dierssen M, Ramakers GJ. Dendritic pathology in mental retardation: from molecular genetics to neurobiology. Genes Brain Behav. 2006, 5 Suppl 2:48-60. 10.1111\/j.1601-183X.2006.00224.x","journal-title":"Genes Brain Behav"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2004.08.001","article-title":"On dendrites in Down syndrome and DS murine models: a spiny way to learn","volume":"74","author":"Benavides-Piccione R","year":"2004","unstructured":"Benavides-Piccione R, Ballesteros-Y\u00e1\u00f1ez I, de Lagr\u00e1n MM, et al.. On dendrites in Down syndrome and DS murine models: a spiny way to learn. Prog Neurobiol. 2004, 74:111-26. 10.1016\/j.pneurobio.2004.08.001","journal-title":"Prog Neurobiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.12.020","article-title":"Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis","volume":"120","author":"Christopherson KS","year":"2005","unstructured":"Christopherson KS, Ullian EM, Stokes CC, et al.. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell. 2005, 120:421-33. 10.1016\/j.cell.2004.12.020","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014200","article-title":"A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down's syndrome","volume":"5","author":"Garcia O","year":"2010","unstructured":"Garcia O, Torres M, Helguera P, Coskun P, Busciglio J. A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down's syndrome. PLoS One. 2010, 5:e14200. 10.1371\/journal.pone.0014200","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.987212","article-title":"Astroglial and microglial pathology in Down syndrome: focus on Alzheimer's disease","volume":"16","author":"Garc\u00eda O","year":"2022","unstructured":"Garc\u00eda O, Flores-Aguilar L. Astroglial and microglial pathology in Down syndrome: focus on Alzheimer's disease. Front Cell Neurosci. 2022, 16:987212. 10.3389\/fncel.2022.987212","journal-title":"Front Cell Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2013.12.024","article-title":"Functional regeneration beyond the glial scar","volume":"253","author":"Cregg JM","year":"2014","unstructured":"Cregg JM, DePaul MA, Filous AR, Lang BT, Tran A, Silver J. Functional regeneration beyond the glial scar. Exp Neurol. 2014, 253:197-207. 10.1016\/j.expneurol.2013.12.024","journal-title":"Exp Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2013.09.056","article-title":"Nucleotide signaling in astrogliosis","volume":"565","author":"Franke H","year":"2014","unstructured":"Franke H, Illes P. Nucleotide signaling in astrogliosis. Neurosci Lett. 2014, 565:14-22. 10.1016\/j.neulet.2013.09.056","journal-title":"Neurosci Lett"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.051508.135600","article-title":"The glial nature of embryonic and adult neural stem cells","volume":"32","author":"Kriegstein A","year":"2009","unstructured":"Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci. 2009, 32:149-84. 10.1146\/annurev.neuro.051508.135600","journal-title":"Annu Rev Neurosci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01015-3","article-title":"Assessment of radial glia in the frontal lobe of fetuses with Down syndrome","volume":"8","author":"Baburamani AA","year":"2020","unstructured":"Baburamani AA, Vontell RT, Uus A, et al.. Assessment of radial glia in the frontal lobe of fetuses with Down syndrome. Acta Neuropathol Commun. 2020, 8:141. 10.1186\/s40478-020-01015-3","journal-title":"Acta Neuropathol Commun"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.611269","article-title":"More than mortar: glia as architects of nervous system development and disease","volume":"8","author":"Lago-Baldaia I","year":"2020","unstructured":"Lago-Baldaia I, Fernandes VM, Ackerman SD. More than mortar: glia as architects of nervous system development and disease. Front Cell Dev Biol. 2020, 8:10.3389\/fcell.2020.611269","journal-title":"Front Cell Dev Biol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00242-3","article-title":"Functional characterization of SOX2 as an anticancer target","volume":"5","author":"Zhang S","year":"2020","unstructured":"Zhang S, Xiong X, Sun Y. Functional characterization of SOX2 as an anticancer target. Signal Transduct Target Ther. 2020, 5:135. 10.1038\/s41392-020-00242-3","journal-title":"Signal Transduct Target Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2013.12.008","article-title":"Treating enhanced GABAergic inhibition in Down syndrome: use of GABA \u03b15-selective inverse agonists","volume":"46 Pt 2","author":"Mart\u00ednez-Cu\u00e9 C","year":"2014","unstructured":"Mart\u00ednez-Cu\u00e9 C, Delatour B, Potier MC. Treating enhanced GABAergic inhibition in Down syndrome: use of GABA \u03b15-selective inverse agonists. Neurosci Biobehav Rev. 2014, 46 Pt 2:218-27. 10.1016\/j.neubiorev.2013.12.008","journal-title":"Neurosci Biobehav Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.10.002","article-title":"GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome","volume":"114","author":"Zorrilla de San Martin J","year":"2018","unstructured":"Zorrilla de San Martin J, Delabar JM, Bacci A, Potier MC. GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome. Free Radic Biol Med. 2018, 114:33-9. 10.1016\/j.freeradbiomed.2017.10.002","journal-title":"Free Radic Biol Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1216575110","article-title":"Deficits in human trisomy 21 iPSCs and neurons","volume":"110","author":"Weick JP","year":"2013","unstructured":"Weick JP, Held DL, Bonadurer GF 3rd, et al.. Deficits in human trisomy 21 iPSCs and neurons. Proc Natl Acad Sci U S A. 2013, 110:9962-7. 10.1073\/pnas.1216575110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201302848","article-title":"Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21","volume":"6","author":"Hibaoui Y","year":"2014","unstructured":"Hibaoui Y, Grad I, Letourneau A, et al.. Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. EMBO Mol Med. 2014, 6:259-77. 10.1002\/emmm.201302848","journal-title":"EMBO Mol Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s1734-1140(10)70369-8","article-title":"Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome","volume":"62","author":"\u015amigielska-Kuzia J","year":"2010","unstructured":"\u015amigielska-Kuzia J, Bo\u0107kowski L, Sobaniec W, Ku\u0142ak W, Sendrowski K. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome. Pharmacol Rep. 2010, 62:1070-7. 10.1016\/s1734-1140(10)70369-8","journal-title":"Pharmacol Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-015-1164-y","article-title":"Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome","volume":"221","author":"Powers BE","year":"2016","unstructured":"Powers BE, Velazquez R, Kelley CM, et al.. Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome. Brain Struct Funct. 2016, 221:4337-52. 10.1007\/s00429-015-1164-y","journal-title":"Brain Struct Funct"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050985","article-title":"The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains","volume":"97","author":"Oka A","year":"1999","unstructured":"Oka A, Takashima S. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains. Acta Neuropathol. 1999, 97:275-8. 10.1007\/s004010050985","journal-title":"Acta Neuropathol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5338-13.2014","article-title":"Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome","volume":"34","author":"Kaur G","year":"2014","unstructured":"Kaur G, Sharma A, Xu W, et al.. Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome. J Neurosci. 2014, 34:5099-106. 10.1523\/JNEUROSCI.5338-13.2014","journal-title":"J Neurosci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/1866-1955-6-42","article-title":"Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy ((1)H MRS)","volume":"6","author":"Tan GM","year":"2014","unstructured":"Tan GM, Beacher F, Daly E, et al.. Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy ((1)H MRS). J Neurodev Disord. 2014, 6:42. 10.1186\/1866-1955-6-42","journal-title":"J Neurodev Disord"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0578-3","article-title":"Metabolomics analysis of children with autism, idiopathic-developmental delays, and Down syndrome","volume":"9","author":"Orozco JS","year":"2019","unstructured":"Orozco JS, Hertz-Picciotto I, Abbeduto L, Slupsky CM. Metabolomics analysis of children with autism, idiopathic-developmental delays, and Down syndrome. Transl Psychiatry. 2019, 9:243. 10.1038\/s41398-019-0578-3","journal-title":"Transl Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236826","article-title":"Phenotype microarrays reveal metabolic dysregulations of neurospheres derived from embryonic Ts1Cje mouse model of Down syndrome","volume":"15","author":"Seth EA","year":"2020","unstructured":"Seth EA, Lee HC, Yusof HH, et al.. Phenotype microarrays reveal metabolic dysregulations of neurospheres derived from embryonic Ts1Cje mouse model of Down syndrome. PLoS One. 2020, 15:10.1371\/journal.pone.0236826","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14260","article-title":"New approaches to studying early brain development in\u00a0Down\u00a0syndrome","volume":"61","author":"Baburamani AA","year":"2019","unstructured":"Baburamani AA, Patkee PA, Arichi T, Rutherford MA. New approaches to studying early brain development in\u00a0Down\u00a0syndrome. Dev Med Child Neurol. 2019, 61:867-79. 10.1111\/dmcn.14260","journal-title":"Dev Med Child Neurol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00202","article-title":"Probing astrocyte metabolism in vivo: proton magnetic resonance spectroscopy in the injured and aging brain","volume":"7","author":"Harris JL","year":"2015","unstructured":"Harris JL, Choi IY, Brooks WM. Probing astrocyte metabolism in vivo: proton magnetic resonance spectroscopy in the injured and aging brain. Front Aging Neurosci. 2015, 7:202. 10.3389\/fnagi.2015.00202","journal-title":"Front Aging Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26178","article-title":"Metabolite signature of Alzheimer's disease in adults with Down syndrome","volume":"90","author":"Montal V","year":"2021","unstructured":"Montal V, Barroeta I, Bejanin A, et al.. Metabolite signature of Alzheimer's disease in adults with Down syndrome. Ann Neurol. 2021, 90:407-16. 10.1002\/ana.26178","journal-title":"Ann Neurol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67195-z","article-title":"Plasma metabolome and cognitive skills in Down syndrome","volume":"10","author":"Antonaros F","year":"2020","unstructured":"Antonaros F, Ghini V, Pulina F, et al.. Plasma metabolome and cognitive skills in Down syndrome. Sci Rep. 2020, 10:10491. 10.1038\/s41598-020-67195-z","journal-title":"Sci Rep"},{"key":"ref40","article-title":"Brain metabolic profile obtained by proton magnetic resonance spectroscopy HMRS in children with Down syndrome","volume":"52","author":"Smigielska-Kuzia J","year":"2007","unstructured":"Smigielska-Kuzia J, Sobaniec W. Brain metabolic profile obtained by proton magnetic resonance spectroscopy HMRS in children with Down syndrome. Adv Med Sci. 2007, 52:183-7.","journal-title":"Adv Med Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2012.04.005","article-title":"Memory aging and brain maintenance","volume":"16","author":"Nyberg L","year":"2012","unstructured":"Nyberg L, L\u00f6vd\u00e9n M, Riklund K, Lindenberger U, B\u00e4ckman L. Memory aging and brain maintenance. Trends Cogn Sci. 2012, 16:292-305. 10.1016\/j.tics.2012.04.005","journal-title":"Trends Cogn Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-017-9220-y","article-title":"Memory profiles in Down syndrome across development: a review of memory abilities through the lifespan","volume":"10","author":"Godfrey M","year":"2018","unstructured":"Godfrey M, Lee NR. Memory profiles in Down syndrome across development: a review of memory abilities through the lifespan. J Neurodev Disord. 2018, 10:5. 10.1186\/s11689-017-9220-y","journal-title":"J Neurodev Disord"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2021.772734","article-title":"Social factors influence behavior in the novel object recognition task in a mouse model of Down syndrome","volume":"15","author":"Sierra C","year":"2021","unstructured":"Sierra C, De Toma I, Cascio LL, Vegas E, Dierssen M. Social factors influence behavior in the novel object recognition task in a mouse model of Down syndrome. Front Behav Neurosci. 2021, 15:10.3389\/fnbeh.2021.772734","journal-title":"Front Behav Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1080\/01942638.2019.1575320","article-title":"Sensory processing and maladaptive behavior: profiles within the Down syndrome phenotype","volume":"39","author":"Will EA","year":"2019","unstructured":"Will EA, Daunhauer LA, Fidler DJ, Raitano Lee N, Rosenberg CR, Hepburn SL. Sensory processing and maladaptive behavior: profiles within the Down syndrome phenotype. Phys Occup Ther Pediatr. 2019, 39:461-76. 10.1080\/01942638.2019.1575320","journal-title":"Phys Occup Ther Pediatr"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.14658\/pupj-ijap-2020-1-5","article-title":"Audiological evaluation in a heterogeneous sample of subjects with Down syndrome","volume":"5","author":"Lacona E","year":"2020","unstructured":"Lacona E, PIatti GMC, Ald\u00e9 M, Ambrosetti U. Audiological evaluation in a heterogeneous sample of subjects with Down syndrome. J Audiol Otol. 2020, 5:15-26. 10.14658\/pupj-ijap-2020-1-5","journal-title":"J Audiol Otol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38520","article-title":"Auditory evoked potentials in children and adolescents with Down syndrome","volume":"176","author":"Gregory L","year":"2018","unstructured":"Gregory L, Rosa RF, Zen PR, Sleifer P. Auditory evoked potentials in children and adolescents with Down syndrome. Am J Med Genet A. 2018, 176:68-74. 10.1002\/ajmg.a.38520","journal-title":"Am J Med Genet A"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.18203\/issn.2454-5929.ijohns20192731","article-title":"Otorhinolaryngological manifestations in Down syndrome: MERF experience","volume":"5","author":"Anto R","year":"2019","unstructured":"Anto R, Natarajan K, Sampathkumar R, Kumar A, Kameswaran M. Otorhinolaryngological manifestations in Down syndrome: MERF experience. Int J Otorhinolaryngol Head Neck Surg. 2019, 5:1065. 10.18203\/issn.2454-5929.ijohns20192731","journal-title":"Int J Otorhinolaryngol Head Neck Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.09.053","article-title":"Characteristics and progression of hearing loss in children with Down syndrome","volume":"193","author":"Kreicher KL","year":"2018","unstructured":"Kreicher KL, Weir FW, Nguyen SA, Meyer TA. Characteristics and progression of hearing loss in children with Down syndrome. J Pediatr. 2018, 193:27-33. 10.1016\/j.jpeds.2017.09.053","journal-title":"J Pediatr"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1352\/1944-7558-125.3.230","article-title":"Physical activity and sedentary behavior among U.S. children with and without Down syndrome: the National Survey of Children's Health","volume":"125","author":"Diaz KM","year":"2020","unstructured":"Diaz KM. Physical activity and sedentary behavior among U.S. children with and without Down syndrome: the National Survey of Children's Health. Am J Intellect Dev Disabil. 2020, 125:230-42. 10.1352\/1944-7558-125.3.230","journal-title":"Am J Intellect Dev Disabil"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/PEP.0000000000000556","article-title":"Physical activity levels of children with Down syndrome","volume":"31","author":"Fox B","year":"2019","unstructured":"Fox B, Moffett GE, Kinnison C, Brooks G, Case LE. Physical activity levels of children with Down syndrome. Pediatr Phys Ther. 2019, 31:33-41. 10.1097\/PEP.0000000000000556","journal-title":"Pediatr Phys Ther"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18105367","article-title":"The test-retest reliability of the Bruininks-Oseretsky test of motor proficiency-short form in youth with Down syndrome\u2014a pilot study","volume":"18","author":"Nocera VG","year":"2021","unstructured":"Nocera VG, Wood AP, Wozencroft AJ, Coe DP. The test-retest reliability of the Bruininks-Oseretsky test of motor proficiency-short form in youth with Down syndrome\u2014a pilot study. Int J Environ Res Public Health. 2021, 18:10.3390\/ijerph18105367","journal-title":"Int J Environ Res Public Health"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007383","article-title":"Analysis of motor dysfunction in Down syndrome reveals motor neuron degeneration","volume":"14","author":"Watson-Scales S","year":"2018","unstructured":"Watson-Scales S, Kalmar B, Lana-Elola E, et al.. Analysis of motor dysfunction in Down syndrome reveals motor neuron degeneration. PLoS Genet. 2018, 14:e1007383. 10.1371\/journal.pgen.1007383","journal-title":"PLoS Genet"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.29081\/gsjesh.2018.19.1.04","article-title":"The role of sensorial integration in motor development in children with Down syndrome","volume":"19","author":"Mihaela A","year":"2018","unstructured":"Mihaela A. The role of sensorial integration in motor development in children with Down syndrome. J Sports Sci. 2018, 19:10.29081\/gsjesh.2018.19.1.04","journal-title":"J Sports Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1589\/jpts.29.123","article-title":"A comparison of the balance and gait function between children with Down syndrome and typically developing children","volume":"29","author":"Jung HK","year":"2017","unstructured":"Jung HK, Chung E, Lee BH. A comparison of the balance and gait function between children with Down syndrome and typically developing children. J Phys Ther Sci. 2017, 29:123-7. 10.1589\/jpts.29.123","journal-title":"J Phys Ther Sci"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.893377","article-title":"Delays in motor development in children with Down Syndrome","volume":"21","author":"Malak R","year":"2015","unstructured":"Malak R, Kostiukow A, Krawczyk-Wasielewska A, Mojs E, Samborski W. Delays in motor development in children with Down Syndrome. Med Sci Monit. 2015, 21:1904-10. 10.12659\/MSM.893377","journal-title":"Med Sci Monit"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8100187","article-title":"DYRK1A protein, a promising therapeutic target to improve cognitive deficits in Down syndrome","volume":"8","author":"Feki A","year":"2018","unstructured":"Feki A, Hibaoui Y. DYRK1A protein, a promising therapeutic target to improve cognitive deficits in Down syndrome. Brain Sci. 2018, 8:10.3390\/brainsci8100187","journal-title":"Brain Sci"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012737","article-title":"Gross motor proficiency and intellectual functioning: a comparison among children with Down syndrome, children with borderline intellectual functioning, and typically developing children","volume":"97","author":"Alesi M","year":"2018","unstructured":"Alesi M, Battaglia G, Pepi A, Bianco A, Palma A. Gross motor proficiency and intellectual functioning: a comparison among children with Down syndrome, children with borderline intellectual functioning, and typically developing children. Medicine (Baltimore). 2018, 97:e12737. 10.1097\/MD.0000000000012737","journal-title":"Medicine (Baltimore)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2017.12.002","article-title":"Cerebellar alterations in a model of Down syndrome: the role of the Dyrk1A gene","volume":"110","author":"Garc\u00eda-Cerro S","year":"2018","unstructured":"Garc\u00eda-Cerro S, Vidal V, Lantigua S, et al.. Cerebellar alterations in a model of Down syndrome: the role of the Dyrk1A gene. Neurobiol Dis. 2018, 110:206-17. 10.1016\/j.nbd.2017.12.002","journal-title":"Neurobiol Dis"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.12659\/MSMBR.910448","article-title":"Contribution of physical and motor characteristics to functional performance in children and adolescents with Down syndrome: a preliminary study","volume":"24","author":"Beqaj S","year":"2018","unstructured":"Beqaj S, T\u00ebrshnjaku EE, Qorolli M, Zivkovic V. Contribution of physical and motor characteristics to functional performance in children and adolescents with Down syndrome: a preliminary study. Med Sci Monit Basic Res. 2018, 24:159-67. 10.12659\/MSMBR.910448","journal-title":"Med Sci Monit Basic Res"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.4236\/wjns.2019.92002","article-title":"Efficacy of sensory integration therapy in improving gross motor coordination and grip control in Down syndrome children","volume":"9","author":"Azzam","year":"2019","unstructured":"Azzam, A. Efficacy of sensory integration therapy in improving gross motor coordination and grip control in Down syndrome children. World J Neurosci. 2019, 9:23-38. 10.4236\/wjns.2019.92002","journal-title":"World J Neurosci"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.32598\/irj.16.3.317","article-title":"The effect of sensory integration on the attention and motor skills of students with Down syndrome","volume":"16","author":"Ashori M","year":"2018","unstructured":"Ashori M, Zarghami E, Ghaforian M, Jalil-Abkenar SS. The effect of sensory integration on the attention and motor skills of students with Down syndrome. Iran Rehabil J. 2018, 16:317-24. 10.32598\/irj.16.3.317","journal-title":"Iran Rehabil J"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.10.006","article-title":"Alzheimer's disease in Down syndrome: an overlooked population for prevention trials","volume":"4","author":"Strydom A","year":"2018","unstructured":"Strydom A, Coppus A, Blesa R, et al.. Alzheimer's disease in Down syndrome: an overlooked population for prevention trials. Alzheimers Dement (N Y). 2018, 4:703-13. 10.1016\/j.trci.2018.10.006","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00245-3","article-title":"Alzheimer's disease associated with Down syndrome: a genetic form of dementia","volume":"20","author":"Fortea J","year":"2021","unstructured":"Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M. Alzheimer's disease associated with Down syndrome: a genetic form of dementia. Lancet Neurol. 2021, 20:930-42. 10.1016\/S1474-4422(21)00245-3","journal-title":"Lancet Neurol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)12987-x","article-title":"Down\u2019s syndrome","volume":"361","author":"Roizen NJ","year":"2003","unstructured":"Roizen NJ, Patterson D. Down\u2019s syndrome. Lancet. 2003, 361:1281-9. 10.1016\/s0140-6736(03)12987-x","journal-title":"Lancet"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.07.026","article-title":"Neurogenesis impairment: an early developmental defect in Down syndrome","volume":"114","author":"Stagni F","year":"2018","unstructured":"Stagni F, Giacomini A, Emili M, Guidi S, Bartesaghi R. Neurogenesis impairment: an early developmental defect in Down syndrome. Free Radic Biol Med. 2018, 114:15-32. 10.1016\/j.freeradbiomed.2017.07.026","journal-title":"Free Radic Biol Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10153414","article-title":"Postnatal cytoarchitecture and neurochemical hippocampal dysfunction in Down syndrome","volume":"10","author":"Moreno DG","year":"2021","unstructured":"Moreno DG, Utagawa EC, Arva NC, Schafernak KT, Mufson EJ, Perez SE. Postnatal cytoarchitecture and neurochemical hippocampal dysfunction in Down syndrome. J Clin Med. 2021, 10:10.3390\/jcm10153414","journal-title":"J Clin Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0559-4","article-title":"The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome","volume":"6","author":"Davidson YS","year":"2018","unstructured":"Davidson YS, Robinson A, Prasher VP, Mann DM. The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome. Acta Neuropathol Commun. 2018, 6:56. 10.1186\/s40478-018-0559-4","journal-title":"Acta Neuropathol Commun"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01356-1","article-title":"The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome","volume":"10","author":"Drummond E","year":"2022","unstructured":"Drummond E, Kavanagh T, Pires G, et al.. The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome. Acta Neuropathol Commun. 2022, 10:53. 10.1186\/s40478-022-01356-1","journal-title":"Acta Neuropathol Commun"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00740-6","article-title":"Alzheimer's disease in Down syndrome: progress in the design and conduct of drug prevention trials","volume":"34","author":"Rafii MS","year":"2020","unstructured":"Rafii MS. Alzheimer's disease in Down syndrome: progress in the design and conduct of drug prevention trials. CNS Drugs. 2020, 34:785-94. 10.1007\/s40263-020-00740-6","journal-title":"CNS Drugs"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.877711","article-title":"Developmental neuropathology and neurodegeneration of Down syndrome: current knowledge in humans","volume":"10","author":"Hasina Z","year":"2022","unstructured":"Hasina Z, Wang N, Wang CC. Developmental neuropathology and neurodegeneration of Down syndrome: current knowledge in humans. Front Cell Dev Biol. 2022, 10:877711. 10.3389\/fcell.2022.877711","journal-title":"Front Cell Dev Biol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.22658","article-title":"Tau PET imaging for staging of Alzheimer's disease in Down syndrome","volume":"79","author":"Rafii MS","year":"2019","unstructured":"Rafii MS. Tau PET imaging for staging of Alzheimer's disease in Down syndrome. Dev Neurobiol. 2019, 79:711-5. 10.1002\/dneu.22658","journal-title":"Dev Neurobiol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30689-9","article-title":"Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study","volume":"395","author":"Fortea J","year":"2020","unstructured":"Fortea J, Vilaplana E, Carmona-Iragui M, et al.. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Lancet. 2020, 395:1988-97. 10.1016\/S0140-6736(20)30689-9","journal-title":"Lancet"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132776","article-title":"Epilepsy in Down syndrome: a highly prevalent comorbidity","volume":"10","author":"Altuna M","year":"2021","unstructured":"Altuna M, Gim\u00e9nez S, Fortea J. Epilepsy in Down syndrome: a highly prevalent comorbidity. J Clin Med. 2021, 10:10.3390\/jcm10132776","journal-title":"J Clin Med"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2022-0067","article-title":"Brain circuit pathology in Down syndrome: from neurons to neural networks","volume":"34","author":"Bartesaghi R","year":"2022","unstructured":"Bartesaghi R. Brain circuit pathology in Down syndrome: from neurons to neural networks. Rev Neurosci. 2022, 34:365-423. 10.1515\/revneuro-2022-0067","journal-title":"Rev Neurosci"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.71061","article-title":"Psychopathology in Down Syndrome. Advances in Research on Down Syndrome","author":"Ersoy SA","year":"2018","unstructured":"Ersoy SA, G\u00fcler HA, \u00c7etin FH. Psychopathology in Down Syndrome. Advances in Research on Down Syndrome. Dey S (ed): IntechOpen Ltd, London, England; 2018. 10.5772\/intechopen.71061"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.17294\/2330-0698.1875","article-title":"Prevalence of mental health conditions among 6078 individuals with Down syndrome in the United States","volume":"9","author":"Rivelli A","year":"2022","unstructured":"Rivelli A, Fitzpatrick V, Chaudhari S, Chicoine L, Jia G, Rzhetsky A, Chicoine B. Prevalence of mental health conditions among 6078 individuals with Down syndrome in the United States. J Patient Cent Res Rev. 2022, 9:58-63. 10.17294\/2330-0698.1875","journal-title":"J Patient Cent Res Rev"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10110786","article-title":"Effects of social isolation and loneliness in children with neurodevelopmental disabilities: a scoping review","volume":"10","author":"Kwan C","year":"2020","unstructured":"Kwan C, Gitimoghaddam M, Collet JP. Effects of social isolation and loneliness in children with neurodevelopmental disabilities: a scoping review. Brain Sci. 2020, 10:10.3390\/brainsci10110786","journal-title":"Brain Sci"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108413","article-title":"Influence of the environment on participation in social roles for young adults with Down syndrome","volume":"9","author":"Foley KR","year":"2014","unstructured":"Foley KR, Girdler S, Bourke J, et al.. Influence of the environment on participation in social roles for young adults with Down syndrome. PLoS One. 2014, 9:e108413. 10.1371\/journal.pone.0108413","journal-title":"PLoS One"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S177973","article-title":"Neuroprogression: the hidden mechanism of depression","volume":"14","author":"Ruiz NA","year":"2018","unstructured":"Ruiz NA, Del \u00c1ngel DS, Olgu\u00edn HJ, Silva ML. Neuroprogression: the hidden mechanism of depression. Neuropsychiatr Dis Treat. 2018, 14:2837-45. 10.2147\/NDT.S177973","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11101278","article-title":"Symptoms of autism spectrum disorder in individuals with Down syndrome","volume":"11","author":"Dimachkie Nunnally A","year":"2021","unstructured":"Dimachkie Nunnally A, Nguyen V, Anglo C, et al.. Symptoms of autism spectrum disorder in individuals with Down syndrome. Brain Sci. 2021, 11:10.3390\/brainsci11101278","journal-title":"Brain Sci"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-019-9306-9","article-title":"Health comorbidities and cognitive abilities across the lifespan in Down syndrome","volume":"12","author":"Startin CM","year":"2020","unstructured":"Startin CM, D'Souza H, Ball G, et al.. Health comorbidities and cognitive abilities across the lifespan in Down syndrome. J Neurodev Disord. 2020, 12:4. 10.1186\/s11689-019-9306-9","journal-title":"J Neurodev Disord"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-021-05016-6","article-title":"Co-occurring Down syndrome and autism spectrum disorder: cognitive, adaptive, and behavioral characteristics","volume":"52","author":"Bradbury KR","year":"2022","unstructured":"Bradbury KR, Anderberg EI, Huang-Storms L, Vasile I, Greene RK, Duvall SW. Co-occurring Down syndrome and autism spectrum disorder: cognitive, adaptive, and behavioral characteristics. J Autism Dev Disord. 2022, 52:1235-46. 10.1007\/s10803-021-05016-6","journal-title":"J Autism Dev Disord"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14850","article-title":"Autism needs to be considered in children with Down syndrome","volume":"108","author":"Wester Oxelgren U","year":"2019","unstructured":"Wester Oxelgren U, \u00c5berg M, Myrelid \u00c5, Anner\u00e9n G, Westerlund J, Gustafsson J, Fernell E. Autism needs to be considered in children with Down syndrome. Acta Paediatr. 2019, 108:2019-26. 10.1111\/apa.14850","journal-title":"Acta Paediatr"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0000000000000745","article-title":"Cognitive profiles and autism symptoms in comorbid Down syndrome and autism spectrum disorder","volume":"41","author":"Hamner T","year":"2020","unstructured":"Hamner T, Hepburn S, Zhang F, Fidler D, Robinson Rosenberg C, Robins DL, Lee NR. Cognitive profiles and autism symptoms in comorbid Down syndrome and autism spectrum disorder. J Dev Behav Pediatr. 2020, 41:172-9. 10.1097\/DBP.0000000000000745","journal-title":"J Dev Behav Pediatr"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2019.03.003","article-title":"Autism spectrum disorder (ASD) symptom profiles of children with comorbid Down syndrome (DS) and ASD: a comparison with children with DS-only and ASD-only","volume":"89","author":"Godfrey M","year":"2019","unstructured":"Godfrey M, Hepburn S, Fidler DJ, Tapera T, Zhang F, Rosenberg CR, Raitano Lee N. Autism spectrum disorder (ASD) symptom profiles of children with comorbid Down syndrome (DS) and ASD: a comparison with children with DS-only and ASD-only. Res Dev Disabil. 2019, 89:83-93. 10.1016\/j.ridd.2019.03.003","journal-title":"Res Dev Disabil"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300117-neurodevelopmental-abnormalities-in-down-syndrome-assessing-structural-and-functional-deficits","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T02:18:51Z","timestamp":1734833931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300117-neurodevelopmental-abnormalities-in-down-syndrome-assessing-structural-and-functional-deficits"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":85,"URL":"https:\/\/doi.org\/10.7759\/cureus.76156","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,21]]}}}